Transcriptional Fingerprinting meets Drug Discovery
Transcriptional Fingerprinting meets Drug Discovery
Transcriptional Fingerprinting meets Drug Discovery
Mission
QUANTRO will combine and exploit innovative technologies in the areas of functional-genetics and transcriptomics to generate an unprecedented cancer drug discovery pipeline transforming the precision and scope of cell-based compound screens.
Read more about the Company & Our Science.
News
22.10.2020
Now hiring: Administrative Assistant
21.07.2020
QUANTRO Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform
20.07.2020
QUANTRO joins Vienna Biocenter
QUANTRO Therapeutics GmbH
Dr. Bohr-Gasse 7
A-1030 Vienna, Austria
© QUANTRO Therapeutics GmbH